FDA Intends to Deactivate Outdated Drug Listing Records as Supply Chain Security Step

“The agency has found that tens of thousands of drug listing records have not been updated or certified in the past year, and are therefore not in compliance with federal regulations…”

The FDA maintains a catalog of drug products commercially distributed in the U.S. Regardless of country of origin, entities that manufacture, repack or re-label drugs in the U.S. are required to register with the FDA, and are required to list drug products manufactured for commercial distribution in the U.S.

The agency has found tens of thousands of drug listings that haven’t been updated (they may no longer be marketed or they are marketed and their listings haven’t been updated). In order keep up-to-date records and make “accurate and timely decisions to protect public health,” they intend to deactivate out-of-date listings, according to a news release.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report